Tetanus is extraordinarily rare in countries with high vaccination rates, and it has been declining globally for decades. In the United States, an average of about 27 cases occur each year, translating to roughly 0.08 cases per million people annually. But “rare” does not mean “gone.” Tetanus cannot be eradicated because the bacterium that causes it lives in the environment, not in human hosts, and in low-income regions it still kills tens of thousands of people each year. The gap between how often tetanus strikes in wealthy nations versus poor ones is one of the starkest vaccination success stories in modern medicine, and understanding the remaining risks matters even if you live somewhere the disease has nearly vanished.
How Many Cases Occur in the United States
Between 2009 and 2023, a total of 402 tetanus cases and 37 deaths were reported across the U.S., averaging about 27 cases and roughly two to three deaths per year. The annual count bounced between 17 and 37 cases, with no upward trend over the 15-year window.1PubMed Central. Tetanus Surveillance – United States, 2009-2023 To put that in perspective, the entire country sees fewer tetanus cases each year than a midsize hospital might see flu patients in a single busy weekend. The numbers are similar in other high-income nations with robust childhood vaccination programs: the United Kingdom, Australia, Canada, Japan, and most of Western Europe each report only a handful of cases annually.
The rarity, however, can breed a dangerous complacency. Because tetanus is so uncommon, many adults in these countries have let their boosters lapse. The disease does not spread person to person, so herd immunity is irrelevant; your protection depends entirely on your own vaccination history. Every case that does occur tends to be someone who was never vaccinated, incompletely vaccinated, or decades past their last booster.
The Global Picture
Worldwide, the trajectory is encouraging but the absolute numbers are still grim in certain regions. Between 1990 and 2019, both incidence and death rates from tetanus fell across the globe. Countries with higher socioeconomic development consistently had lower rates, while the heaviest burden remained in Sub-Saharan Africa, South Asia, and Southeast Asia.2PubMed. Global epidemiology and burden of tetanus from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019 In low-income areas, the age profile of tetanus flips compared to wealthy nations. Newborns account for a disproportionate share of cases in countries where maternal vaccination is spotty and deliveries happen in unhygienic settings. In high-income countries, by contrast, about half of cases occur in adults aged 70 and older.
Among children under five, global tetanus cases dropped from roughly 309,000 in 1990 to about 18,000 in 2021, and the mortality rate in that age group fell from about 25 per 100,000 to just over 1 per 100,000.3PubMed Central. Global analysis of tetanus incidence and mortality in children under 5 years: findings from the Global Burden of Disease Study 2021 Those gains are real, but they are unevenly distributed. Regions with the lowest socioeconomic development still carry incidence and mortality rates many times higher than the global average.
Neonatal and Maternal Tetanus
Neonatal tetanus has been one of the most devastating forms of the disease. In 1988, an estimated 787,000 newborns died from it worldwide. By 2010 that number had fallen to around 58,000, a reduction of about 93%, largely because of a World Health Organization initiative promoting maternal vaccination and clean delivery practices.4PubMed Central. Elimination of Maternal and Neonatal Tetanus Without any medical care, neonatal tetanus is almost always fatal. Even with hospital treatment, mortality ranges from roughly 10% to 60% depending on whether intensive care is available.
Maternal tetanus, which occurs during pregnancy or within six weeks of delivery or pregnancy termination, was estimated to cause between 15,000 and 30,000 cases per year in the early 1990s.5PubMed. Maternal tetanus: magnitude, epidemiology and potential control measures Septic deliveries and unsafe abortions are the typical triggers. Vaccinating pregnant women with tetanus toxoid protects both the mother and the newborn through passively transferred antibodies, which is why the WHO’s elimination strategy targets maternal immunization as its cornerstone.
Who Gets Tetanus Today
In wealthy countries where childhood vaccination is routine, the people who develop tetanus tend to share a few characteristics: they are older, they never completed their vaccine series, or they belong to specific high-risk groups.
- Older adults: A large U.S. serologic survey found that protective tetanus antibody levels dropped from about 88% among children aged 6 to 11 to just 28% among adults aged 70 and older.6PubMed. A Population-Based Serologic Survey of Immunity to Tetanus in the United States Most of the tetanus cases and deaths reported in the U.S. during the late 1980s and early 1990s clustered in people over 60. Research in Austria confirmed a steep decline in post-vaccination antibody levels starting around age 40, with people over 60 frequently falling below protective thresholds.7PubMed. Insufficient protection for healthy elderly adults by tetanus and TBE vaccines
- Unvaccinated or undervaccinated individuals: This includes people who were never vaccinated as children and those who emigrated from countries without reliable immunization programs. Among U.S. cases, a large majority had either no documented vaccination or an incomplete series.
- People who inject drugs: An outbreak of tetanus among injecting drug users was reported across England, Scotland, and Wales in the early 2000s.8Weekly releases (1997–2007). Ongoing outbreak of tetanus in injecting drug users in the UK Contaminated heroin and unsanitary injection practices create ideal conditions for spore entry.
In a study from Thailand, about 84% of elderly people still had antibody levels above the minimum protective level for tetanus, but only about a third had levels considered durably protective.9PubMed Central. Seroprevalence of an antibody against diphtheria, tetanus, and pertussis among the elderly in Khon Kaen, Thailand The practical takeaway is that even in populations with historically good vaccine uptake, a sizeable fraction of older adults walk around with antibody levels too low to fend off infection after a wound.
Where the Bacteria Actually Lives
Most people associate tetanus with rusty nails, but the connection between rust and tetanus is indirect at best. The real culprit is Clostridium tetani, a spore-forming bacterium. Its spores can survive in the environment for years, waiting for anaerobic conditions (low oxygen) inside a wound to germinate and produce toxin.10European Journal of Soil Science. A review of the abundance, behaviour and detection of clostridial pathogens in agricultural soils
A study that tested environmental samples for C. tetani DNA produced a result that surprises most people: only about 1 in 140 soil samples tested positive. Meanwhile, 75% of rusted metal and concrete surface samples carried the bacterium’s DNA, and 30% of dog feces samples were positive.11PubMed Central. An Assessment of the Presence of Clostridium tetani in the Soil and on Other Surfaces The rusty-nail reputation has some basis in reality: rough, corroded surfaces can harbor spores and also create the kind of deep, jagged puncture wound that provides an oxygen-poor environment for germination. But the bacterium is not unique to rust. Any wound contaminated with spores, including scrapes, burns, surgical sites, and animal bites, can be the entry point.
What Tetanus Does to the Body
When spores germinate in a wound, the bacteria produce tetanus toxin, one of the most potent biological toxins known. The toxin travels along nerve fibers from the wound site to the spinal cord and brainstem, where it blocks the release of chemicals that normally keep muscles from firing uncontrollably. The result is sustained, involuntary muscle contraction.12PubMed Central. Tetanus: pathophysiology, treatment, and the possibility of using botulinum toxin against tetanus-induced rigidity and spasms
The most recognized symptom is lockjaw: the jaw muscles clamp shut and the person cannot open their mouth. From there, stiffness and spasms can spread to the neck, back, abdomen, and limbs. In severe cases, spasms of the respiratory and throat muscles can cause suffocation. Tetanus exists in four clinical forms. Generalized tetanus, which involves the whole body, is by far the most common and the most dangerous. Localized tetanus confines stiffness and spasms to the area near the wound. Cephalic tetanus affects cranial nerves after a head wound. Both localized and cephalic forms are much rarer.13PubMed Central. A Rare Case of Localized Tetanus
How Deadly Is Tetanus
The mortality numbers vary enormously depending on where you get sick and how old you are. In the United States, the overall case-fatality rate for reported tetanus between 2009 and 2023 was about 12%. But that average obscures a steep age gradient: among adults 65 to 79 the rate was around 31%, and among those 80 and older it reached 63%. The vast majority of U.S. tetanus deaths, about 84%, occurred in people 65 and older. Cephalic tetanus carried the highest fatality rate of any clinical form, at roughly 67%, compared with about 12% for generalized tetanus.1PubMed Central. Tetanus Surveillance – United States, 2009-2023
In lower-resource hospital settings, the picture is far worse. A study at hospitals in Bahir Dar, Ethiopia found an in-hospital mortality rate of about 32% among adult tetanus patients. Patients who had generalized tetanus faced about 6.5 times the odds of dying compared to those with other forms, and those with a short onset time (symptoms appearing within two days of the wound) had about four times the odds of death.14PubMed Central. Mortality and Associated Factors Among Adult Tetanus Patients Admitted at Public Hospitals in Bahir Dar City, Ethiopia A multicenter study in Bangladesh reported a similar mortality rate of about 34%, with age over 40 and a short onset time again emerging as the strongest predictors of death.15PLOS Neglected Tropical Diseases. Factors associated with in-hospital mortality of adult tetanus patients–a multicenter study from Bangladesh
The pattern across all these studies is consistent. Older patients, those who develop symptoms quickly after a wound, those with generalized rather than localized disease, and those who do not receive tetanus antitoxin promptly are far more likely to die. Access to intensive care with mechanical ventilation is the single biggest variable separating a 12% fatality rate from one above 30%.
Booster Timing and the Question of Waning Immunity
Standard guidelines in most countries recommend a tetanus booster every ten years. Yet a study of Portuguese women who had completed a full childhood vaccination schedule of six tetanus toxoid doses found that protective antibody levels persisted well beyond a decade, suggesting that booster intervals of 20 years might be sufficient for people who actually completed the full childhood series.16PubMed Central. Levels of diphtheria and tetanus specific IgG of Portuguese adult women, before and after vaccination with adult type Td. Duration of immunity following vaccination The catch is that many adults did not complete a full series, or received fewer doses than modern schedules recommend. For those people, immunity may wane faster.
This creates a practical dilemma. If you are a healthy 35-year-old who had all your childhood shots and a booster in your twenties, your risk from a missed ten-year booster is genuinely tiny. But if you are 70, even with a good vaccination history, your immune system produces weaker and shorter-lived responses to booster shots. That is why elderly adults account for such a disproportionate share of cases and deaths in wealthy countries: their immune systems both lose protection faster and rebuild it less effectively.
Unexpected Routes of Infection
When people think about tetanus-prone wounds, they picture stepping on a nail or cutting themselves on farm equipment. Those scenarios are real, but they are not the only ones. Dental infections and dental procedures have been documented as the entry point for tetanus in a small but recurring number of cases. A systematic review found that almost three-quarters of reported dental-associated tetanus cases followed a dental procedure, mainly tooth extraction, while about 23% were linked to tooth decay itself.17PubMed Central. Tetanus secondary to oral and odontogenic infections: a case report and systematic literature review This is rare enough that many dentists have never seen a case, but it underscores that any break in tissue where spores can enter qualifies as a potential route.
Other documented but uncommon entry points include ear infections, chronic skin ulcers, surgical wounds, and even insect bites. The unifying factor is not the type of wound but the conditions inside it: a deep or poorly oxygenated wound contaminated with spores. Clean, superficial cuts that bleed freely are far less hospitable to the bacterium.
Autonomic Storms and Recovery
Even when patients survive the muscle spasms that define tetanus, they often face a second, less well-known threat. Severe tetanus frequently triggers autonomic dysfunction: wild swings in heart rate, blood pressure, and temperature that can be life-threatening on their own. One case report described alternating episodes of dangerously slow and dangerously fast heart rate alongside blood pressure that lurched unpredictably.18PubMed Central. Tetanus Complicated by Dysautonomia: A Case Report and Review of Management In another case, cardiovascular instability was most severe during the first two weeks but blood pressure fluctuations persisted for about six weeks, and the patient did not recover enough to eat on their own for eight weeks.19Annals of Clinical Neurophysiology. Autonomic instability in severe tetanus: a case report
Recovery from tetanus is slow. The toxin binds irreversibly to nerve endings, so the body has to grow new nerve terminals before normal signaling resumes. Hospital stays are measured in weeks, not days. A study of tetanus inpatients in Korea found a median hospital stay of 39 days. About two-thirds of patients required mechanical ventilation, and roughly 40% developed aspiration pneumonia as a complication. The median total healthcare cost per patient was about $18,000.20PubMed Central. Clinical outcomes and healthcare costs of inpatients with tetanus in Korea, 2011-2019 In low-income settings, intrathecal administration of antitetanus immunoglobulin has been shown to reduce both the severity of illness and overall treatment costs substantially.21PubMed. Incremental costs of treating tetanus with intrathecal antitetanus immunoglobulin
One detail that surprises many people: surviving tetanus does not make you immune. The amount of toxin needed to cause disease is too small to trigger a lasting immune response. Patients who recover need a full vaccination course afterward just as if they had never been infected.
Why Tetanus Cannot Be Eradicated
Unlike smallpox or polio, tetanus will never be wiped off the planet. The bacterium is not passed from person to person; it lives in soil, dust, and animal intestines and forms spores that persist in the environment indefinitely. You cannot vaccinate your way to a world without the pathogen, only to a world where vaccinated individuals are protected when they encounter it. This makes tetanus fundamentally different from diseases targeted by eradication campaigns.22PubMed Central. Tetanus: historical and palaeopathological aspects considering its current health impact Even if every human on Earth were vaccinated today, the spores in the soil would still be there tomorrow. The moment vaccination coverage slips, cases return.
Tetanus in Animals
Humans are not the only species affected. Horses and sheep are highly sensitive to tetanus toxin, while cattle, dogs, and cats are comparatively resistant.23PubMed Central. Tetanus in animals Horse owners will recognize tetanus vaccination as a standard part of equine care; the disease progresses rapidly in horses and is frequently fatal without treatment. The variable susceptibility across species is thought to reflect differences in how the toxin binds to nerve tissue, not differences in exposure. Horses and livestock that graze in pastures, sustain hoof injuries, and are routinely in contact with soil-borne spores face constant exposure, yet their outcomes depend on whether they have been vaccinated, just as in humans.
Wound management after an injury also follows the same logic in veterinary medicine. Cleaning the wound, creating aerobic conditions, administering antitoxin, and ensuring the animal’s vaccination is current are the pillars of prevention. The parallels underscore a basic truth about this disease: tetanus is a problem of environment, wounds, and immune status, regardless of the species involved.